These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23815025)

  • 1. [Healthcare expenditure].
    Huguier M
    Bull Acad Natl Med; 2012 Oct; 196(7):1443-9. PubMed ID: 23815025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.
    Ojo K; Delaney M
    Int J Health Plann Manage; 1997; 12(4):315-26. PubMed ID: 10177418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.
    Yelin E; Herrndorf A; Trupin L; Sonneborn D
    Arthritis Rheum; 2001 May; 44(5):1160-9. PubMed ID: 11352250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost containment and new priorities in the European community.
    Abel-Smith B
    Milbank Q; 1992; 70(3):393-416. PubMed ID: 1406493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Private expenditure in health by state in Mexico].
    Sesma-Vázquez S; Pérez-Rico R; Martínez-Monroy T; Lemus-Carmona EA
    Salud Publica Mex; 2005; 47 Suppl 1():S27-36. PubMed ID: 16101204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost of multiple sclerosis in France].
    Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of asthma in the United States.
    Weiss KB; Gergen PJ; Hodgson TA
    N Engl J Med; 1992 Mar; 326(13):862-6. PubMed ID: 1542323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public healthcare expenditure in Spain: measuring the impact of driving factors.
    Blanco-Moreno Á; Urbanos-Garrido RM; Thuissard-Vasallo IJ
    Health Policy; 2013 Jun; 111(1):34-42. PubMed ID: 23597871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national profile of health care utilization and expenditures for children with special health care needs.
    Newacheck PW; Kim SE
    Arch Pediatr Adolesc Med; 2005 Jan; 159(1):10-7. PubMed ID: 15630052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financing dental care: trends in public and private expenditures for dental services.
    Bailit H; Beazoglou T
    Dent Clin North Am; 2008 Apr; 52(2):281-95, v. PubMed ID: 18329444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating medical costs of work-related diseases in the Basque Country (2008).
    Gómez MG; Castañeda R; Menduiña PL; Garrido RU; Markowitz S
    Med Lav; 2013; 104(4):267-76. PubMed ID: 24228305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The drug budget silo mentality: the French case.
    Le Pen C
    Value Health; 2003; 6 Suppl 1():S10-9. PubMed ID: 12846922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study.
    Muratov S; Lee J; Holbrook A; Guertin JR; Mbuagbaw L; Paterson JM; Gomes T; Pequeno P; Tarride JE
    BMJ Open; 2019 Oct; 9(10):e028637. PubMed ID: 31662356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.